Brian Burkavage

Director of Finance/CFO at DAMORA THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Brian Burkavage is Chief Financial & Accounting Officer at Damora Therapeutics, Inc. starting in 2026.
Former positions include Chief Accounting Officer at IO Biotech, Inc. from 2022 to 2025, Controller at Passage Bio, Inc. from 2020 to 2021, and Director-Financial Planning & Analysis at Aclaris Therapeutics, Inc. from 2017 to 2020.
Education includes undergraduate and graduate degrees from the University of Notre Dame.

Brian Burkavage active positions

Companies	Position	Start
DAMORA THERAPEUTICS, INC.	Director of Finance/CFO	01/05/2026

All active positions of Brian Burkavage

Former positions of Brian Burkavage

Companies	Position	End
IO BIOTECH, INC.	Comptroller/Controller/Auditor	12/12/2025
PASSAGE BIO, INC.	Comptroller/Controller/Auditor	01/01/2021
ACLARIS THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2020

See the detail of Brian Burkavage's experience

Education of Brian Burkavage

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian Burkavage's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Notre Dame University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases	Health Technology
Passage Bio, Inc. Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders	Health Technology
Galecto, Inc. Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases	Health Technology
IO Biotech, Inc. IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies	Health Technology